Covid-19 virus via Columbia University
Since the first reports of a new coronavirus disease in Wuhan, China, in December 2019, COVID-19 has spread rapidly across the globe, threatening a pandemic. Now, researchers from CAS, a division of the American Chemical Society specializing in scientific information solutions, have issued a special report in ACS Central Science. In the report, they provide an overview of published scientific information on potential therapeutic agents and vaccines for the virus, with an emphasis on patents.
According to the World Health Organization, as of March 2, 2020, COVID-19 caused almost 90,000 confirmed illnesses and more than 3,000 deaths. The responsible virus, known as SARS-CoV-2, primarily attacks the lower respiratory system to cause viral pneumonia, but it may also affect the gastrointestinal system, heart, kidney, liver and central nervous system. If SARS-CoV-2 is not quickly contained, the virus could have devastating effects on people’s lives, worldwide health systems and the global economy. To assist with research efforts to discover therapies and vaccines for COVID-19, Cynthia Liu led a group of CAS scientists who analyzed the published scientific data on SARS-CoV-2 and related coronaviruses.
The researchers reviewed the rapidly growing body of journal articles related to COVID-19 and SARS-CoV-2, as well as patents having to do with human coronaviruses. From the last week of 2019 through March 1, 2020, more than 500 journal articles related to the virus were published electronically or in print, with numbers steadily increasing week-by-week. Topics included clinical manifestations, treatment regimens, viral structure and mechanisms, antiviral agents, and diagnostics. To date, more than 500 patents have been issued for vaccines and for therapeutic agents, such as antibodies, cytokines and nucleic acids, that could help prevent or treat coronavirus infections. Because SARS-CoV-2 is similar to other coronaviruses, such as SARS-CoV-1 and MERS-CoV, the researchers highlighted therapies previously explored for these other viruses that could also be applicable to SARS-CoV-2.
The authors do not acknowledge any funding sources for this study.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Australia expects COVID-19 vaccination is still a year awayon October 7, 2020 at 2:57 am
Australia considered a rollout of a coronavirus vaccine no sooner than mid-2021 a best-case scenario in its pandemic planning that would save the economy tens of billions of dollars, the treasurer ...
- Czech COVID-19 Cases Rising at Fastest Rate in Europeon October 7, 2020 at 2:46 am
The Czech Republic reported a record 4,457 new coronavirus cases in a single day, Health Ministry data showed on Wednesday, as a spike in infections over the past month is now rising at Europe's ...
- From Trump on down, people of means have shaped our COVID-19 experience. That must change.on October 7, 2020 at 2:42 am
White House butlers, maids, plumbers, florists, doormen and cooks were not in that Rose Garden photo and their positive COVID tests don't make headlines.
- Pence, Harris to debate in sole VP matchup of 2020 amid heightened COVID-19 concernson October 7, 2020 at 2:41 am
Vice President Mike Pence and Sen. Kamala Harris of California will debate in Salt Lake City on Tuesday in the sole matchup between the 2020 vice presidential candidates.
- Hospitals Failing To Meet New COVID-19 Data Reporting Mandate To Get Warning Letterson October 7, 2020 at 2:30 am
New enforcement guidelines are now in place, pushing hospitals to comply with rigorous reporting requirements, or risk losing a crucial funding stream from the federal government.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Some states plan to vet Covid-19 vaccines themselves. Bad idea, experts say.on October 7, 2020 at 2:12 am
California and at least five other states have said they may independently vet any vaccines, but experts warn that could needlessly confuse the public.
- White House approves new COVID-19 vaccine standards after FDA publishes them anywayon October 7, 2020 at 1:51 am
The White House on Tuesday, in an apparent reversal, approved stringent new Food and Drug Administration guidelines for emergency use approval of a COVID-19 vaccine. The Trump administration was ...
- China's experimental COVID-19 vaccine appears safe - studyon October 7, 2020 at 12:20 am
A Chinese experimental coronavirus vaccine being developed by the Institute of Medical Biology under the Chinese Academy of Medical Sciences was shown to be safe in an early stage clinical trial, ...
- US Agency Wants 2 Months Safety Data Before Approving Covid-19 Vaccineon October 6, 2020 at 11:16 pm
The US Food and Drug Administration made public its guidance for issuing emergency approval for a Covid-19 vaccine on Tuesday, making it clear it wants to see follow-up two months after trial ...
- President Donald Trump says COVID-19 vaccines are coming 'momentarily.' Scientists say they're not.on October 6, 2020 at 9:09 pm
President Donald Trump said COVID-19 vaccines Are coming "momentarily." Doctors and scientists have repeatedly refuted that claim.